Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa. ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.35 | -15.0862068966 | 2.32 | 2.4428 | 1.9 | 653949 | 2.04833559 | CS |
| 4 | -0.41 | -17.2268907563 | 2.38 | 2.67 | 1.9 | 343313 | 2.20680425 | CS |
| 12 | -1.3 | -39.755351682 | 3.27 | 3.27 | 1.9 | 417592 | 2.39040026 | CS |
| 26 | 0.12 | 6.48648648649 | 1.85 | 4.62 | 1.65 | 939369 | 3.57372146 | CS |
| 52 | 0.07 | 3.68421052632 | 1.9 | 4.62 | 1.61 | 530144 | 3.38289242 | CS |
| 156 | 1.0599 | 116.4597297 | 0.9101 | 4.62 | 0.53 | 727818 | 2.32830964 | CS |
| 260 | -5.53 | -73.7333333333 | 7.5 | 9.46 | 0.53 | 808265 | 4.20178408 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
